NAME,SpMAX4_Bh(s),Experimental INP Formation,SpMAX4_Bh(s) Analysis GroupABT737,7,Yes,ValidationApitolisib,5.01,No,ValidationAvagacestat,8,Yes,ValidationAvasimibe,4.79,Yes,ValidationAZD-4547,4.72,No,ValidationBiminetinib,6.46,No,ValidationBithionol,4.94,No,ValidationBMS-777607,7.41,Yes,ValidationCamptotecin,4.99,No,TrainingCelecoxib,7.73,Yes,ValidationCholecalciferol,4.29,No,ValidationCholesterol,4.25,No,ValidationDabrafenib,7.72,Yes,ValidationDactolisib,4.93,No,ValidationDocetaxel,7.43,Yes,TrainingDutasteride,8,Yes,ValidationEnzalutamide,8,Yes,TrainingErlotinib,4.67,No,TrainingEverolimus,7.42,Yes,ValidationForskolin,6.44,No,ValidationFulvestrant,8,Yes,TrainingGefitinib,4.76,No,ValidationGlimepiride,7.41,Yes,ValidationGlybenclamide,7,Yes,ValidationIdelalisib,4.83,No,TrainingINK128,4.75,No,ValidationIpatasertib,4.93,No,ValidationLapatinib,5.12,No,TrainingLuminespib,5.19,No,ValidationMGCD-265,4.9,No,ValidationMubritinib,5.17,No,ValidationNilotinib,7.43,Yes,ValidationOspemifene,4.71,No,ValidationPaclitaxel,7.43,Yes,TrainingPanobinostat,4.76,No,ValidationPazopanib,4.98,No,ValidationPluripotin,7.43,Yes,ValidationProbucol,4.59,No,ValidationRapamycin,7.42,Yes,TrainingRegorafenib,8,Yes,ValidationRO4929097,8,Yes,ValidationSelumetinib,5,No,TrainingSilvesterol,4.97,No,TrainingSorafenib,7.43,Yes,TrainingSunitinib,4.82,No,TrainingTacrolimus,7.35,Yes,ValidationTAK-632,8,Yes,ValidationTalazoparib,5.07,No,ValidationTanespimycin,7.42,Yes,ValidationTaselisib,4.89,No,TrainingTazarotene,4.48,No,ValidationTerbinafine,4.29,No,ValidationTrametinib,7.43,Yes,TrainingValdecoxib,4.83,No,ValidationValrubicin,7.44,Yes,ValidationVemurafenib,7.43,Yes,ValidationVenetoclax,7,Yes,TrainingVerapamil,4.5,No,ValidationVoxtalisib,4.62,No,ValidationZSTK474,4.91,No,Validation